Mangoceuticals Partners With Greater NY Chamber Of Commerce For Mass Marketing & Sales Of Flagship Mango Product
Portfolio Pulse from Benzinga Newsdesk
Mangoceuticals, Inc. (NASDAQ:MGRX) has partnered with the Greater NY Chamber of Commerce (GNYCC) to market and sell its flagship erectile dysfunction drug, Mango, in New York. The partnership is part of Mangoceuticals' nationwide push to drive sales growth and new marketing avenues for its core product portfolio. The GNYCC, which represents over 30,000 business and civic leaders, will provide complimentary access to Mango as part of their new Men's Health & Wellness committee. This move follows Mangoceuticals' recent marketing and sales expansion efforts, including its appointment of Lucky Break PR firm and sponsorship relationships with leading social media and podcast brands.
August 09, 2023 | 12:25 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Mangoceuticals' partnership with GNYCC to market and sell its flagship product, Mango, in New York could potentially drive sales growth and increase brand awareness. This move, along with recent marketing and sales expansion efforts, could positively impact the company's stock in the short term.
The partnership with GNYCC provides Mangoceuticals with a significant platform to market and sell its flagship product, Mango, in New York, a state that consistently features in the top five U.S. states for most erectile dysfunction medication sales. This, coupled with the company's recent marketing and sales expansion efforts, could potentially drive sales growth and increase brand awareness, which could positively impact the company's stock in the short term.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100